Mediolanum International Funds Ltd Makes New $1.62 Million Investment in GE HealthCare Technologies Inc. $GEHC

Mediolanum International Funds Ltd bought a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 1st quarter, HoldingsChannel.com reports. The firm bought 23,603 shares of the company’s stock, valued at approximately $1,623,000.

Other hedge funds also recently modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of GE HealthCare Technologies by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock worth $4,287,658,000 after buying an additional 267,058 shares during the period. Auto Owners Insurance Co raised its position in GE HealthCare Technologies by 9,525.4% during the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after buying an additional 33,629,559 shares during the period. Dodge & Cox lifted its stake in GE HealthCare Technologies by 13.4% in the 4th quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock worth $2,559,945,000 after acquiring an additional 3,693,918 shares in the last quarter. Capital Research Global Investors boosted its position in GE HealthCare Technologies by 1.6% during the 4th quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock worth $2,080,248,000 after acquiring an additional 389,796 shares during the period. Finally, State Street Corp boosted its position in GE HealthCare Technologies by 2.0% during the 4th quarter. State Street Corp now owns 20,049,677 shares of the company’s stock worth $1,644,475,000 after acquiring an additional 401,932 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Peter J. Arduini acquired 4,169 shares of the firm’s stock in a transaction that occurred on Thursday, April 30th. The stock was purchased at an average cost of $59.92 per share, for a total transaction of $249,806.48. Following the completion of the acquisition, the chief executive officer owned 259,424 shares of the company’s stock, valued at approximately $15,544,686.08. This trade represents a 1.63% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Kevin Lobo bought 10,000 shares of the stock in a transaction on Friday, May 22nd. The shares were acquired at an average cost of $64.18 per share, for a total transaction of $641,800.00. Following the completion of the transaction, the director directly owned 14,363 shares of the company’s stock, valued at approximately $921,817.34. The trade was a 229.20% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased a total of 21,847 shares of company stock valued at $1,361,355 in the last three months. 0.36% of the stock is currently owned by company insiders.

GE HealthCare Technologies Trading Down 1.3%

Shares of NASDAQ GEHC opened at $62.04 on Wednesday. The business has a 50 day simple moving average of $63.66 and a 200 day simple moving average of $71.60. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77. The stock has a market cap of $28.22 billion, a price-to-earnings ratio of 14.84, a PEG ratio of 1.71 and a beta of 0.72. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The business had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. GE HealthCare Technologies’s revenue was up 7.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, research analysts predict that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 24th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies’s payout ratio is presently 3.35%.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. Stifel Nicolaus set a $80.00 target price on GE HealthCare Technologies in a report on Wednesday, April 29th. UBS Group lowered their price objective on shares of GE HealthCare Technologies from $69.00 to $67.00 and set a “neutral” rating on the stock in a research report on Thursday, July 16th. Citigroup reiterated a “neutral” rating on shares of GE HealthCare Technologies in a research note on Wednesday, July 8th. BTIG Research reissued a “buy” rating and set a $75.00 target price on shares of GE HealthCare Technologies in a research note on Monday, July 13th. Finally, BMO Capital Markets started coverage on shares of GE HealthCare Technologies in a report on Wednesday, July 8th. They set a “market perform” rating and a $70.00 price target on the stock. Ten investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Hold” and an average target price of $76.41.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.